Grünenthal Bolsters its Pain Pipeline with Thar Acquisition
By Jawala Prasad
Pharma Deals Review: Vol 2016 Issue 12 (Table of Contents)
Published: 20 Dec-2016
DOI: 10.3833/pdr.v2016.i12.2212 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Grünenthal has added another orphan disease drug to its pipeline to treat complex regional pain syndrome (CRPS) by acquiring US-based Thar Pharmaceuticals for an undisclosed amount...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS